317450.KS · 명인제약

South Korea · RS rating 39 · As of 2026-11-04

Price40,600.00 KRW
1-day change+0.7%
RS rating (overall / 1M / 3M / 12M)39 / 61 / 45 / 11
StageDeclining
Composite / Minervini / CANSLIM score27 / 11 / 29
Industry group (rank)Medical-Products (85)
EPS growth Q/Q+7.0%
Sales growth Q/Q+5.5%
Distance from 52-week high+55.4%
Market cap (USD)$444.6M
Open South Korea in the interactive screener